Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Harpe Bio

Explore full profile

Resistance to herbicides is causing weeds to flourish in crops, resulting in billions of dollars in annual losses

Raleigh, United StatesFounded 2020Food
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Harpe Bio and the history behind them.

About Harpe Bio

Harpe Bioherbicide Solutions, Inc. operates as an agricultural technology firm, directing its focus on the development of natural weed management solutions. Founded in 2020 and headquartered in Raleigh, North Carolina, the company is addressing the escalating issue of herbicide resistance and the growing market demand for sustainable farming practices. The leadership team includes CEO Bill Buckner, an executive with an extensive background in agricultural technology, including 18 years at Bayer Group where he rose to President and CEO of Bayer CropScience LP. He is joined by co-founder and CTO Dr. Chad Brommer, a scientist with a background in herbicide research and development at BASF.

The company's core business revolves around a platform of proprietary biological herbicide formulations derived from a series of plant extracts, including those from the mentha (mint) family. These formulations are designed to control a wide spectrum of broadleaf and grass weeds, including those that have developed resistance to common synthetic herbicides like glyphosate, dicamba, and atrazine. Harpe Bio's products feature new sites and modes of action, which can help mitigate the further development of weed resistance. The business model targets two primary market segments: organic agriculture and conventional farming. For the organic market, the company offers stand-alone, all-natural herbicide solutions for pre- and post-emergent use. For conventional agriculture, its products are designed to be used as tank-mix partners, synergizing with existing synthetic herbicides to enhance their effectiveness and reduce the total amount of chemicals needed.

Harpe Bio is advancing its product development through extensive greenhouse and field trials and is moving toward commercial-ready formulations, with plans for regulatory submissions and select market introductions potentially as early as 2026. The company has successfully raised capital to fund its research and development, including a significant investment round led by ADM, a global leader in mint production. This strategic partnership provides Harpe with key inputs for its products. Beyond its herbicide formulations, the company is also developing herbicide-tolerant crop systems, which would allow for the in-season application of its natural herbicides.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Raleigh, United States
Employees
9
Open positions
None listed
Dealroom signal
37.9/100
Industry
Food
Sub-industry
AgriTech
Sector
Food, Crop Protection, Sustainable Development Goals, Regenerative Agriculture, Climate Tech, nt
Business model
Manufacturing
Client focus
b2b

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC May 2024 $500K $53M Undisclosed ↗
GRANT✓Other financing Jul 2023 $275K — US National Science Foundation ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Harpe Bio website traffic

Latest recorded traffic for Harpe Bio is 2.1K monthly website visits, down 22.2% over the last three months. Harpe Bio's team declined 18.2% over the past year.

Latest monthly visits2.1K 3-month web change-22.2% 1-year team growth-18.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A4 investors entered at this stage

  • Alexandria Venture Investments
  • iSelect Fund
  • AgriTech Capital
  • Archer Daniels Midland
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States88.9%
🇩🇪 Germany11.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Harpe Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Harpe Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.